[Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus].
Bourguet
P
P
Médecin nucléaire, Centre Eugène-Marquis, Rennes.
Hitzel
A
A
Houvenaeghel
G
G
Vinatier
D
D
Bosquet
L
L
Bonichon
F
F
Corone
C
C
Giard-Lefèvre
S
S
Morett
J-L
JL
Touboul
E
E
D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000592:standards*; D019275:Radiopharmaceuticals; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18